Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Kerstin Bettermann"'
Autor:
Svetlana A Dambinova, Kerstin Bettermann, Theodore Glynn, Matthew Tews, David Olson, Joseph D Weissman, Richard L Sowell
Publikováno v:
PLoS ONE, Vol 8, Iss 3 (2013)
[This corrects the article DOI: 10.1371/journal.pone.0042362.].
Externí odkaz:
https://doaj.org/article/08b6601229aa42fb895e247e2cbe7466
Autor:
Svetlana A Dambinova, Kerstin Bettermann, Theodore Glynn, Matthew Tews, David Olson, Joseph D Weissman, Richard L Sowell
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e42362 (2012)
The acute assessment of patients with suspected ischemic stroke remains challenging. The use of brain biomarker assays may improve the early diagnosis of ischemic stroke. The main goal of the study was to evaluate whether the NR2 peptide, a product o
Externí odkaz:
https://doaj.org/article/5255dc62b08b4489978857c28df2f09b
Autor:
Jennifer E. Nyland, Nazia Raja-Khan, Kerstin Bettermann, Philippe Haouzi, Douglas L. Leslie, Patricia S. Grigson, Leslie J. Parent, Jennifer L. Kraschnewski
Publikováno v:
Diabetes
Patients with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-19 outcomes possibly due to dysregulated inflammatory responses. Glucose-regulating medications such as glucagon-like peptide-1 receptor (GLP-1R) agonists, dipeptidyl
Publikováno v:
Neurochemistry international. 139
Diabetic mice exhibit increased mortality and morbidity following stroke. Recent studies from our laboratory have indicated that increased morbidity in diabetic db/db mice relative to their non-diabetic db/+ littermates is associated with increased l
Publikováno v:
Medical Research Archives. 8
Diabetic and hyperglycemic stroke patients have worse clinical outcome, higher mortality rates, larger infarcts, and more severe neurological disability than euglycemic individuals. The reasons for the worse outcome in diabetes are poorly understood,
Autor:
Nazia Raja-Khan, Leslie J. Parent, Jennifer E. Nyland, Philippe Haouzi, Kerstin Bettermann, Patricia S. Grigson, Jennifer L. Kraschnewski
Publikováno v:
SSRN Electronic Journal.
Background: The risk of severe COVID-19 is potentiated by dysregulated inflammatory responses to the virus, and individuals with type 2 diabetes mellitus (T2DM) are particularly vulnerable. Glucose-regulating medications such as glucagon-like peptide
Autor:
Kerstin Bettermann, Kusum Sinha
Publikováno v:
Neuromethods ISBN: 9781493996810
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8644e6201b3998024ccad798c39451cd
https://doi.org/10.1007/978-1-4939-9682-7_13
https://doi.org/10.1007/978-1-4939-9682-7_13
Publikováno v:
Drug discovery today. 25(4)
Vascular dementia (VaD) is a progressive neurocognitive clinical syndrome that is caused by a decrease in cerebral blood flow and damage to the neurovascular unit. Given increasing life expectancy, VaD is emerging as one of the leading health problem
Autor:
Kerstin Bettermann, Kusum Sinha
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 69
Acute ischemic strokes (AIS) with severe neurologic deficits are associated with poor short- and long-term prognosis. Thrombectomy alone or in combination with thrombolysis is used for reperfusion in patients with moderate-to-severe AIS. However, the
Autor:
Julia E. Slocomb, David A. Quillen, Thomas W. Gardner, Vikram Shivkumar, Mary E. J. Lott, Kerstin Bettermann
Publikováno v:
Journal of Neuroimaging. 27:78-84
Diabetes is a common cause of small vessel disease leading to stroke and vascular dementia. While the function and structure of large cerebral vessels can be easily studied, the brain's microvasculature remains difficult to assess. Previous studies h